We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Martin Midstream Partners
MMLP
$95.9M
| $98.5M | 0.12% |
4,917,651
+395,996
| +9% | +$8.51M |
|
202
M&T Bank
MTB
$36.2B
| $98M | 0.12% |
843,690
-835,844
| -50% | -$97.1M |
|
|
RDS.A
203
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $96.7M | 0.12% |
1,932,277
+243,665
| +14% | +$12.4M |
|
|
CEQP
204
DELISTED
Crestwood Equity Partners LP
CEQP
| $96.5M | 0.12% |
4,540,419
+264,870
| +6% | +$5.53M |
|
205
Whirlpool
WHR
$2.42B
| $95.4M | 0.12% |
588,053
-89,308
| -13% | -$15.8M |
|
206
Visa
V
$677B
| $94.9M | 0.12% |
1,146,980
-329,925
| -22% | -$26.4M |
|
207
Macerich
MAC
$7.32B
| $92.6M | 0.12% |
1,145,025
+15,160
| +1% | +$1.28M |
|
|
MRSH
208
Marsh
MRSH
$86.3B
| $91.9M | 0.12% |
1,366,270
-654,059
| -32% | -$43.8M |
|
|
ULTI
209
DELISTED
Ultimate Software Group Inc
ULTI
| $91.1M | 0.11% |
445,905
+12,581
| +3% | +$2.66M |
|
210
Welltower
WELL
$178B
| $90.3M | 0.11% |
1,208,287
-69,757
| -5% | -$5.34M |
|
211
MacroGenics
MGNX
$235M
| $89.8M | 0.11% |
3,000,820
+20,160
| +0.7% | +$600K |
|
212
Ross Stores
ROST
$76.6B
| $89.4M | 0.11% |
1,390,200
-428,261
| -24% | -$26.3M |
|
|
LLL
213
DELISTED
L3 Technologies, Inc.
LLL
| $89M | 0.11% |
590,203
-146,786
| -20% | -$21.9M |
|
|
RMP
214
DELISTED
Rice Midstream Partners LP
RMP
| $88.6M | 0.11% |
3,653,527
-162,000
| -4% | -$3.41M |
|
|
SAGE
215
DELISTED
Sage Therapeutics
SAGE
| $88.2M | 0.11% |
1,915,874
+1,145,717
| +149% | +$46.6M |
|
216
Intel
INTC
$466B
| $88M | 0.11% |
2,330,164
+1,922,741
| +472% | +$68.1M |
|
217
Viatris
VTRS
$20.1B
| $87.8M | 0.11% |
2,303,746
+264,356
| +13% | +$11.8M |
|
218
Dentsply Sirona
XRAY
$2.59B
| $87.1M | 0.11% |
1,466,425
-41,180
| -3% | -$2.53M |
|
219
Teva Pharmaceuticals
TEVA
$35.9B
| $87.1M | 0.11% |
1,892,375
-143,185
| -7% | -$7.47M |
|
220
Lowe's Companies
LOW
$116B
| $85.8M | 0.11% |
1,187,596
+1,116,139
| +1,562% | +$86.8M |
|
221
Spectrum Brands
SPB
$2.04B
| $85.6M | 0.11% |
621,966
+119,511
| +24% | +$15.2M |
|
222
Lennox International
LII
$18.8B
| $84.5M | 0.11% |
537,960
+39,774
| +8% | +$6.18M |
|
223
Boston Properties
BXP
$11B
| $84.1M | 0.11% |
616,998
+49,518
| +9% | +$6.87M |
|
224
Globant
GLOB
$1.35B
| $84M | 0.11% |
1,994,764
+20,680
| +1% | +$845K |
|
225
Invesco Senior Loan ETF
BKLN
$7.1B
| $83.5M | 0.1% |
3,598,890
+3,341,985
| +1,301% | +$77.4M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.